Brief: PMV Pharmaceuticals Q2 EPS USD -0.34
14/08/2026 13:01
BRIEF-PMV Pharmaceuticals Q2 EPS USD -0.34 Aug 14 (Reuters) - PMV Pharmaceuticals Q2 operating expenses USD 18.881 million.
- Q2 operating income USD -18.881 million
- Q2 net income USD -18.086 million
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics